Decay Kinetics of HIV With the Integrase Inhibitor Raltegravir.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 22 May 2015
At a glance
- Drugs Efavirenz; Emtricitabine/tenofovir disoproxil fumarate; Raltegravir
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 25 Oct 2011 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 05 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.